About JSCO

TOP > About JSCO > About JSCO
Message from the Chairman
Aims and Projects
Members and Admission
Organizational Structure
Number of the members
JSCO History
Reguration and COI Policy
Statements and Declarations



The Japan Society of Clinical Oncology (JSCO) is a leading Japanese professional organization founded in 1963 that has been committed to advancing the specialty of clinical oncology and promoting a multidisciplinary approach in cancer treatment and care. Its members include physicians and healthcare professionals at all levels of oncology practice.

The mission of the JSCO is to study malignant disorders and achieve progress in the treatment of them.

 Figure 1. Trend in members of JSCO

More than 17,000 oncology practitioners currently belong to the JSCO. The number of members is continuing to increase (Figure 1) and the JSCO is now the largest clinical oncology organization in Japan (Figure 2). Its members are in specialties covering more than 20 diverse fields, and include surgeons, medical oncologists, urologists, gynecologists, radiologists and others.

Figure 2. JSCO is the largest medical organization of clinical oncology in Japan

More than 9,900 participants attended the 53rd Annual Meeting of Japan Society of Clinical Oncology (JSCO2015) held on October 29-31, 2015, in Kyoto, Japan (Figure 3).

Figure 3. Trend in Participants and Announcements in Annual Meeting